Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mallinckrodt plc (NY: MNK )

N/A UNCHANGED
Last Price Updated: 8:00 PM EDT, Aug 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.3100 (2)
Ask (Size) 0.3250 (1)
Prev. Close 0.3402
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 84,715,878
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's Going On With Silence Therapeutics Stock Today?
Silence Therapeutics reports narrower Q4 loss, data from zerlasiran study, and strengthened cash position. In March 2024, Mallinckrodt notified Silence that they will not pursue further development of... 
Via Benzinga
Mallinckrodt's Bankruptcy Plan Approved, Wiping Out Over $1B Meant for Opioid Overdose Crisis
Mallinckrodt plc (OTC: MNKTQ), one of the largest manufacturers of prescription opioids in the U.S., has secured court approval for a plan that erases over $1 billion in payments intended for peo 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal

Performance

More News

Read More
Mallinckrodt Plc (NYSE: MNK) Investor Alert: Deadline in Lawsuit on September 5, 2023
Via SBWire
Topics Lawsuit
Exposures Financial Legal
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc (MNK)
From The Law Offices of Frank R. Cruz
Via Business Wire
Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories
Via Benzinga
Hit By Opioid Lawsuits Mallinckrodt Files For Second Bankruptcy In Just Three Years
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Legal
Rite Aid Once Top Drugstore Chain Lost Over 80% Of Stock Value In One Year: Opioid Litigation Takes Toll
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Legal
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Airbnb Versus New York Regulations, Netflix Adds New US Users After Password Crackdown, Facebook Marketplace Under Regulatory Fire For Alleged Sale Of Recalled Items: Top Stories
Via Benzinga
Nikola Preps for Resale of 10 Million Shares of NKLA Stock
Via InvestorPlace
MNK Stock Alert: Mallinckrodt Files for Bankruptcy Again
Via InvestorPlace
Topics Bankruptcy
Exposures Financial Legal
150-Year Old Opioid Drugmaker Mallinckrodt Files For Bankruptcy For Second Time
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Addiction Treatment Market May See New Emerging Trends: Novartis, Pfizer, Sanofi
Via SBWire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Mallinckrodt Plc (NYSE: MNK) Investor Alert: Lawsuit Alleges False and Misleading Statements
Via SBWire
Topics Lawsuit
Exposures Financial Legal
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why TETRA Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.